Global News

Gilead Sciences to acquire YM Biosciences

Wednesday, December 12, 2012 11:17 AM

Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., has signed a definitive agreement to acquire YM BioSciences, a drug development company based in Canada, for $2.95 per share in cash. 

More... »

GSK, Fred Hutchinson Cancer Research Center to develop muscular dystrophy therapeutics

Wednesday, December 12, 2012 10:19 AM

Fred Hutchinson Cancer Research Center and global healthcare company GlaxoSmithKline (GSK) have formed a partnership to develop therapeutics to treat an inherited form of muscular dystrophy.

More... »

Isis, AZ form strategic alliance on RNA therapeutics for cancer

Wednesday, December 12, 2012 09:51 AM

Isis Pharmaceuticals of Carlsbad, Calif., and global biopharmaceutical company AstraZeneca have formed a strategic alliance for the discovery and development of novel generation antisense therapeutics against five cancer targets, which includes a license to develop and commercialize ISIS-STAT3Rx, a drug Isis is currently evaluating in an early clinical trial in patients with advanced lymphomas.

More... »

inVentiv Health strengthens clinical leadership team

Monday, December 10, 2012 02:12 PM

inVentiv Health, a global provider of clinical, commercial and consulting services, has appointed Raymond Hill as executive vice president of clinical. Hill will be responsible for leading the company's clinical business segment, which includes early stage, phase II-IV and strategic resourcing.

More... »

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

AMRI, GE Healthcare extend long term supply relationship

Monday, December 10, 2012 01:16 PM

AMRI, a global contract research and manufacturing organization, has extended its commercial supply relationship with GE Healthcare for Aminobisamide Hydrochloride (ABA).

More... »

Drug discovery services market to reach $16.6B in 2015

Monday, December 10, 2012 10:09 AM

A new report by visiongain, an independent media company based in London, predicts that the world market for drug discovery outsourcing will reach $16.6 billion in 2015. That revenue forecast and others appear in “DrugDiscovery Outsourcing: World Market 2013-2023,” published in November 2012.

More... »

Amgen to acquire deCODE Genetics

Monday, December 10, 2012 09:40 AM

Amgen, a biotech based in Thousand Oaks, Calif., has entered into a definitive agreement to acquire deCODE Genetics, an Iceland-based company that analyzes the human genome.

More... »

UT MD Anderson, GSK collaborate on new approach to cancer immune therapy

Friday, December 7, 2012 02:06 PM

The University of Texas MD Anderson Cancer Center and global healthcare company GlaxoSmithKline (GSK) have signed a research collaboration and license agreement to develop new therapeutic antibodies that promote an immune system attack against cancer.

More... »

Cenduit launches new study supply simulation and forecasting service

Friday, December 7, 2012 11:41 AM

Cenduit, a provider of interactive response technology (IRT)-driven services for clinical trials, has introduced a new study simulation and forecasting service that will enable clinical trial sites to better plan and control supplies for their patients. When integrated with Cenduit’s interactive response technology (IRT) services, the new service will give sponsors complete confidence in their clinical supply chain.

More... »